Dr. Andrew Clarke


+61 7 3185 3350
Email Dr. Andrew

Passionate about the biotech industry - particularly biomedical and health research sectors – Dr. Andrew Clarke heads James & Wells’ biotechnology team in Australia. Andrew has an impressive track record of managing IP portfolios for universities, large research organisations, ASX-listed companies, and start-ups. Andrew specialises in the preparation and prosecution of patent applications in a diverse array of biotech fields including immunology, antibody technologies, vaccines (cell, peptide and small molecule), molecular biology, cell therapies and bioinformatics.

A keen sportsman, outside the office Andrew can typically be found playing soccer, tennis, Aussie rules, or Gaelic football. He was a member of the British Olympic Fencing Team and a previous British number one.

Service Areas


Recommended by the prestigious IAM Patent 1000 for patent prosecution in Australia, Andrew has significant experience working with companies and technologies in the biotech industry to develop their IP strategies, and protect and commercialise their inventions.

Andrew’s PhD investigated the recognition of self-antigens by a host with a view to developing improved treatments for autoimmune diseases and cancer. His research was published in top tier journals including 'Nature' and 'Immunity'.

Andrew is the former Director and Co-Founder of boutique Australian intellectual property firm Innofy – a firm acquired by James & Wells in 2019. Prior to Innofy, Andrew worked for Davies Collison Cave.

Qualifications & Memberships

  • PhD (Biochemistry)
  • Master of Science (Biochemistry)
  • Master of Intellectual Property
  • Registered Patent Attorney – Australia and New Zealand
  • Registered Trade Mark Attorney – Australia
  • Member - International Association for the Protection of Intellectual Property (AIPPI) Biotechnology Standing Committee (2017-present)
  • Member - Intellectual Property Society of Australia and New Zealand (IPSANZ) Queensland Committee (2015-present)
  • Expert intellectual property panel member - AusBiotech (2018-present)

Recently published by Dr. Andrew